sanofi-aventis (Thailand) Ltd.
Pharmaceutical and Consumer Healthcare
- Marine Queniart-Stojanovic, General Manager, Thailand, Malaysia, Singapore, Myanmar and Brunei
- Chamaiporn Noonbhakdi , Thailand Public Affairs and Market Access Head
- Panchanit Snape, Head of Communications, Thailand, Malaysia, Singapore, Myanmar and Brunei
87/2 CRC Tower, 24th Fl., All Seasons Place, Wireless Rd., Lumpini, Pathumwan, Bangkok 10330 Thailand
+66 (0) 2 264 9999
+66 (0) 2 264 9998
Our local presence includes:
Pharmaceutical market: Providing leading therapeutic solutions for cardiovascular, thrombosis, diabetes, oncology, internal medicine, rare diseases, and central nervous system
Growing Consumer Healthcare Business Unit led by the feminine hygiene wash Lactacyd And a footprint in rare diseases such as Genetic Lysosomal Storage Disorders (Gaucher, Pompe, MPS and Fabry)
Thailand Public Affairs and Market Access Head
Contact information for member only.
Sanofi, a global healthcare leader, discovers, develops and distributes therapeutic solutions focused on patients' needs. Sanofi has core strengths in diabetes and cardiovascular, vaccines, rare diseases, consumer healthcare, emerging markets.
Sanofi is listed in Paris (EURONEXT: SAN) and in New York (NYSE: SNY).
Sanofi has its roots in Thailand since 1965 when Hoechst Pharmaceutical Industries registered, and became sanofi-aventis (Thailand) Ltd in 2006. Sanofi Group is present through 4 entities: Sanofi, Sanofi Pasteur, and the GPOMBP Ltd. (Government Pharmaceutical Organization-Merieux Biological Product), a joint venture between GPO, Sanofi Pasteur and CPB Equity Ltd. dedicated to the downstream production of vaccines for the local public market.